Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year ...
Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies ...
Americans spend more on prescription drugs than anyone else in the world. It’s true that they take a lot of pills. But what really sets the US apart is how much drugs cost. Unlike in most other ...
Robert F. Kennedy, Jr. (RFK), secretary of the U.S. Department of Health and Human Services (HHS), appeared at a recent ...
Several pharmaceutical companies have said they will sell drugs directly to patients in the US and offer discounts ...
The Trump administration is hinting at an upcoming rule aimed at implementing the President’s “most favored nation” drug pricing policy. The proposed policy is titled “global benchmark for efficient ...
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month ...
Ascletis Pharma announced new preclinical and Phase Ib clinical results for its portfolio of next-generation obesity drug candidates, including ASC36, ASC35, and ASC30, developed using its proprietary ...
(CN) — A Ninth Circuit panel on Tuesday freed Oregon to enforce its Prescription Drug Price Transparency Act of 2018, which will require pharmaceutical companies to disclose certain information about ...
In Greek mythology, Achilles’s mother Thetis sought to ensure his invulnerability by dipping him into the gods’ River Styx. Her effort would have succeeded but for the one spot where she held him—his ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results